The principle of immune checkpoint blockade therapy is based on the activation of T cells. Immune checkpoint inhibitors (ICIs), such as anti-PD-1/PD-L1 and anti-CTLA-4 antibodies, have demonstrated ...

1 Department of Pharmacy, The Affiliated Yixing Hospital of Jiangsu University, Yixing, China 2 Department of pharmacy, Jiangsu Province Hospital, Nanjing, China Immunotherapy has become a global ...